ATE495192T1 - Mit voluminösen oder lipophilen gruppen modifizierte cyctotoxische peptide - Google Patents

Mit voluminösen oder lipophilen gruppen modifizierte cyctotoxische peptide

Info

Publication number
ATE495192T1
ATE495192T1 AT99941773T AT99941773T ATE495192T1 AT E495192 T1 ATE495192 T1 AT E495192T1 AT 99941773 T AT99941773 T AT 99941773T AT 99941773 T AT99941773 T AT 99941773T AT E495192 T1 ATE495192 T1 AT E495192T1
Authority
AT
Austria
Prior art keywords
cyctotoxic
voluminous
lipophilic groups
peptides modified
well
Prior art date
Application number
AT99941773T
Other languages
English (en)
Inventor
John Svendsen
Yystein Rekdal
Baldur Sveinbjyrnsson
Lars Vorland
Original Assignee
Lytix Biopharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lytix Biopharma As filed Critical Lytix Biopharma As
Application granted granted Critical
Publication of ATE495192T1 publication Critical patent/ATE495192T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT99941773T 1998-08-28 1999-08-31 Mit voluminösen oder lipophilen gruppen modifizierte cyctotoxische peptide ATE495192T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9818938.4A GB9818938D0 (en) 1998-08-28 1998-08-28 Bioactive peptides
PCT/GB1999/002850 WO2000012541A2 (en) 1998-08-28 1999-08-31 Cytotoxic peptides modified by bulky or lipophilic moieties

Publications (1)

Publication Number Publication Date
ATE495192T1 true ATE495192T1 (de) 2011-01-15

Family

ID=10838089

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99941773T ATE495192T1 (de) 1998-08-28 1999-08-31 Mit voluminösen oder lipophilen gruppen modifizierte cyctotoxische peptide
AT99941774T ATE513847T1 (de) 1998-08-28 1999-08-31 Bioaktive peptide

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT99941774T ATE513847T1 (de) 1998-08-28 1999-08-31 Bioaktive peptide

Country Status (12)

Country Link
US (3) US6890902B2 (de)
EP (2) EP1109827B1 (de)
JP (1) JP5475937B2 (de)
AT (2) ATE495192T1 (de)
AU (2) AU5526899A (de)
CA (2) CA2341037C (de)
DE (1) DE69943130D1 (de)
DK (1) DK1109831T3 (de)
ES (1) ES2359616T3 (de)
GB (1) GB9818938D0 (de)
NO (1) NO333073B1 (de)
WO (2) WO2000012541A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
GB0605685D0 (en) * 2006-03-21 2006-05-03 Lytix Biopharma As Inhibition of tumour growth
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
GB0005702D0 (en) * 2000-03-09 2000-05-03 Alpharma As Method
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
KR20020080731A (ko) * 2001-04-17 2002-10-26 주식회사 이지바이오 시스템 락토페리신 유전자 및 이를 도입한 락토페리신 발현용형질전환체
KR100454595B1 (ko) * 2001-11-30 2004-10-28 주식회사 이지바이오 시스템 락토페리신 유전자 및 이를 도입한 형질전환 대장균
SE0200598D0 (sv) * 2002-02-27 2002-02-27 A & Science Invest Ab Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences
US20040082504A1 (en) 2002-05-10 2004-04-29 Atul Varadhachary Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
AU2003247826B2 (en) * 2002-06-28 2008-04-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
NO20031818D0 (no) * 2003-04-23 2003-04-23 Uni I Tromsoe Fremgangsmåte av bioaktiv peptid forberedelse
US8105615B2 (en) * 2003-06-06 2012-01-31 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
US7419667B2 (en) * 2004-03-19 2008-09-02 Morinaga Milk Industry Co. Ltd. Drug for cancer therapy
KR20070056042A (ko) * 2004-06-17 2007-05-31 맨카인드 코포레이션 에피토프 유사체
US8034762B2 (en) * 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
US7183381B2 (en) * 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
CA2587727A1 (en) * 2004-11-19 2006-05-26 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
DE102005051366A1 (de) * 2005-10-25 2007-04-26 Degussa Gmbh Drug Delivery Systeme
WO2007055578A1 (en) * 2005-11-11 2007-05-18 Leids Universitair Medisch Centrum Cyclic antimicrobial peptides derived from lactoferrin
US20100061932A1 (en) 2005-12-30 2010-03-11 Evonik Roehm Gmbh Peptides useful as cell-penetrating peptides
ES2321358B1 (es) * 2006-04-05 2010-03-05 Consejo Susperior De Investigaciones Cientificas Uso de peptidos derivados de la lactoferrina para preparar formulaciones inhibidoras de la enzima conversora de angiotensina i.
EP2010561A4 (de) * 2006-04-27 2010-03-24 Singapore Health Services Pte Antimikrobielle peptide
WO2008006125A1 (en) 2006-07-10 2008-01-17 Österreichische Akademie der Wissenschaften Antimicrobial peptides
GB0821616D0 (en) * 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
EP2754450A1 (de) 2013-01-11 2014-07-16 Österreichische Akademie der Wissenschaften Aus Lactoferricin abgeleitete Peptide
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
CN106794218A (zh) * 2014-10-08 2017-05-31 学校法人庆应义塾 白细胞的细胞外诱捕网形成抑制剂
ITUB20153058A1 (it) * 2015-08-11 2017-02-11 Farmagens Health Care S R L Roma ?frammento di lattoferrina per uso come agente antibatterico ed antivirale?
US11213512B2 (en) 2016-06-21 2022-01-04 The Curators Of The University Of Missouri Bis-amino acid based compound and use thereof
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
AU2018312110B2 (en) 2017-08-04 2023-03-16 Bioventures, Llc Linear lipopeptide paenipeptins and methods of using the same
US11236138B2 (en) * 2020-01-14 2022-02-01 Renorigin Innovation Institute Co., Ltd. Peptide, method and composition for melanin polymerization and hair darkening
CN115073352A (zh) * 2022-06-28 2022-09-20 吉尔多肽生物制药(大连市)有限公司 一种2,5,7-三叔丁基色氨酸的合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141581A (en) * 1972-10-08 1992-08-25 Markham Harold A Implants with a cover which resists formation of firm spherical encapsulation
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US5073542A (en) 1989-06-07 1991-12-17 Magainin Sciences Inc. CPF peptide compositions and their use in inhibiting growth of target cells or a virus
DK167813B1 (da) * 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US5141851A (en) * 1990-04-18 1992-08-25 Board Of Regents, The University Of Texas System Isolated farnesyl protein transferase enzyme
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
DE69220397T2 (de) * 1991-03-13 1997-10-02 Morinaga Milk Industry Co Ltd Antimikrobielles Peptid und antimikrobieller Wirkstoff
CA2111214A1 (en) * 1991-06-12 1992-12-23 W. Lee Maloy Composition and treatment with biologically active peptides having c-terminal substitutions
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US5631228A (en) * 1991-11-01 1997-05-20 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
CA2128612C (en) 1992-01-23 1999-06-15 Mamoru Tomita Antimicrobial agents and method for treating products therewith
AU674525B2 (en) * 1992-06-01 1997-01-02 Magainin Pharmaceuticals, Inc. Biologically active peptides having N-terminal substitutions
CA2140002A1 (en) * 1992-07-13 1994-01-20 Jay Stout A chemical method for selective modification of the n- and/or c-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof
US5593866A (en) 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
JPH08507749A (ja) 1992-12-03 1996-08-20 マガイニン ファーマシューティカルズ，インク． 皮膚悪性疾患の生物学的活性を有するペプチドによる治療
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
EP0920331A1 (de) * 1996-08-12 1999-06-09 A+ Science Invest AB Behandlung und verhütung von infektionen, entzündungen und/oder tumoren mit hilfe von lactoferrin und /oder lactoferricin
CN1228123A (zh) * 1996-08-14 1999-09-08 诺瓦提斯公司 对植物病原真菌有抑制活性的肽
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
WO1998040091A1 (en) * 1997-03-13 1998-09-17 The Research Foundation Of State University Of New York Microbicidal peptides and methods of use
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides

Also Published As

Publication number Publication date
NO20010995L (no) 2001-04-27
DK1109831T3 (da) 2011-04-18
US20030022821A1 (en) 2003-01-30
EP1109831B1 (de) 2011-01-12
ES2359616T3 (es) 2011-05-25
US8143211B2 (en) 2012-03-27
EP1109831A2 (de) 2001-06-27
WO2000012542A2 (en) 2000-03-09
JP2002523517A (ja) 2002-07-30
EP1109827A2 (de) 2001-06-27
US7439228B2 (en) 2008-10-21
DE69943130D1 (de) 2011-02-24
AU5526799A (en) 2000-03-21
NO333073B1 (no) 2013-02-25
CA2340326A1 (en) 2000-03-09
AU772176B2 (en) 2004-04-08
WO2000012541A2 (en) 2000-03-09
CA2341037A1 (en) 2000-03-09
US6890902B2 (en) 2005-05-10
JP5475937B2 (ja) 2014-04-16
ATE513847T1 (de) 2011-07-15
EP1109827B1 (de) 2011-06-22
AU5526899A (en) 2000-03-21
WO2000012541A3 (en) 2000-06-08
NO20010995D0 (no) 2001-02-27
GB9818938D0 (en) 1998-10-21
US20080287346A1 (en) 2008-11-20
CA2341037C (en) 2013-11-05
US20030148936A1 (en) 2003-08-07
WO2000012542A3 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
ATE495192T1 (de) Mit voluminösen oder lipophilen gruppen modifizierte cyctotoxische peptide
ES2103857T3 (es) Peptidos ciclicos y su uso.
ES2163444T3 (es) Composiciones y metodos para la administracion oral de farmacos.
MX172600B (es) , "procedimiento para la produccion de una proteina biologicamente activa
PL344599A1 (en) Novel cyclosporins
IL127352A (en) Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
BR9807076B1 (pt) "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica"
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
DE69900756D1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
FR2647677B1 (fr) Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
MX9302327A (es) Aminoacidos ciclicos novedosos y derivados de los mismos.
HK1040237A1 (en) Fused polycyclic amino acids as pharmaceutical agents.
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
FR2766489B1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
AR018328A1 (es) Forma cristalina de la 1s-[1 alfa(2s*,3r*), 9 alfa-]-6,10-dioxo-n-(2-etoxi-5-oxo-tetrahidro-3-furanil)-9-[[(1-isoquinolil)carbonil]amino]octahidro-6-h-piridazino[1,2-a][1,2] diazepina-1-carboxamida, su procedimiento de preparacion , su aplicacion en la preparacion de un medicamento, y las composicio
DE69808287T2 (de) Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1109831

Country of ref document: EP